Navamedic ASA (OSL:NAVA)

Navamedic ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	67.1	74.16	37.29	38.04	55.3	52.62
Cash & Short-Term Investments	67.1	74.16	37.29	38.04	55.3	52.62
Cash Growth	66.46%	98.89%	-1.97%	-31.21%	5.09%	32.93%
Accounts Receivable	48.77	43.3	45.59	38.04	39.46	31.36
Other Receivables	10.34	12.65	10.37	16.83	18.43	22.03
Receivables	59.1	55.94	55.96	54.87	98.51	90.99
Inventory	105.85	116.56	81.89	105.2	79.64	61.88
Prepaid Expenses	-	15.93	8.67	10.62	-	-
Other Current Assets	11.18	9.3	16.19	1.39	10.09	-0
Total Current Assets	243.23	271.88	200	210.12	243.54	205.49
Property, Plant & Equipment	6.07	6.19	8.74	9.75	7.12	8.31
Long-Term Investments	-	-	-	-	-	18.84
Goodwill	197.63	207.57	159.05	156.73	100.74	61.03
Other Intangible Assets	237.75	250.89	92.56	97.63	30.54	27.34
Long-Term Deferred Tax Assets	0.93	0.93	0.93	0.93	0.84	9.17
Total Assets	690.02	741.75	467.48	507.32	382.77	330.18

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	65.45	90.63	50.27	68.3	65.57	70.53
Accrued Expenses	-	43.1	47.05	42.45	40.07	29.72
Current Portion of Long-Term Debt	44.23	40.69	35.44	51.07	13.62	9.75
Current Portion of Leases	2.31	2.52	2.87	2.45	1.87	1.84
Current Income Taxes Payable	7.17	6.03	5.2	8.15	4.71	10.71
Other Current Liabilities	46.48	4.75	-0	16.86	0.22	13.16
Total Current Liabilities	165.64	187.73	140.82	189.28	126.06	135.71
Long-Term Debt	157.14	165	78.57	95.48	38.37	29.24
Long-Term Leases	1.05	0.01	1.69	3.89	4.86	5.82
Long-Term Deferred Tax Liabilities	7	7.75	8.36	9.27	-	-
Other Long-Term Liabilities	46.29	47.18	21.36	3.99	3.76	8.17
Total Liabilities	377.12	407.67	250.8	301.91	173.05	178.94

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	17.75	17.75	13.07	12.84	12.75	12.1
Additional Paid-In Capital	314.46	314.46	198.24	192.58	190.41	165.83
Retained Earnings	-19.3	1.88	5.36	-0.02	6.56	-26.69
Comprehensive Income & Other	0	-	0	-0	-	-
Shareholders' Equity	312.9	334.08	216.67	205.4	209.72	151.24
Total Liabilities & Equity	690.02	741.75	467.48	507.32	382.77	330.18

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	204.74	208.22	118.57	152.89	58.72	46.64
Net Cash (Debt)	-137.64	-134.07	-81.29	-114.86	-3.42	5.98
Net Cash Growth	-	-	-	-	-	-64.41%
Net Cash Per Share	-6.72	-7.04	-4.65	-6.65	-0.20	0.36
Filing Date Shares Outstanding	23.4	23.98	17.66	17.35	17.23	16.35
Total Common Shares Outstanding	23.4	23.98	17.66	17.35	17.23	16.35
Working Capital	77.59	84.16	59.18	20.84	117.48	69.78
Book Value Per Share	13.37	13.93	12.27	11.84	12.17	9.25
Tangible Book Value	-122.48	-124.38	-34.94	-48.95	78.44	62.86
Tangible Book Value Per Share	-5.23	-5.19	-1.98	-2.82	4.55	3.85
Machinery	-	7.87	7.18	5.18	1.18	1.14

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error